In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
Pictured: Three-dimensional structure of the protein mTOR
In the Lab
A Recently Revealed Protein Structure Creates New Opportunities for Cancer Research and Drug Design

In an eagerly awaited study, Memorial Sloan Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer.
Pictured: Timothy Chan
In the Lab
Investigators Sequence the Genome of a Rare Head and Neck Cancer

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.
Charles Sawyers, Kenneth Offit, and Larry Norton
Honors
Three Memorial-Sloan Kettering Researchers Receive Special Awards by the American Society of Clinical Oncology

Charles Sawyers, Larry Norton, and Kenneth Offit are being honored with special awards at the annual meeting of the world’s leading professional organization for cancer physicians and researchers.
Pictured: Siddhartha Mukherjee
Event
Pulitzer Prize-winning Author Siddhartha Mukherjee Addresses 2013 Graduates

Physician-scientist Siddhartha Mukherjee, author of <em>The Emperor of All Maladies: A Biography of Cancer</em>, spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery.
Pictured: Melanocytes
Snapshot
Pigment-Producing Skin Cells Generated Using Stem Cell Technology

Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.
Pictured: Christopher Lima
Honors
Structural Biologist Christopher Lima Named Howard Hughes Medical Institute Investigator

Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.
Pictured: Charles Sawyers
In the Lab
Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.
Imagination to Discovery

Three emerging investigators are tackling the mysteries of biology and cancer at Memorial Sloan Kettering.
Pictured: Kenneth Offit
Finding
New Findings May Lead to Better Predictions of Breast Cancer Risk in Women with Inherited Mutations

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.
In the Clinic
Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.